Amantadine hydrochloride - Parkinson's disease
You are here : Home > Formulary Search > Amantadine hydrochloride - Parkinson's disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (National)
PAD Profile
ChemicalSubstance :
Amantadine hydrochloride
Indication :
Parkinson's disease
Group Name :
Keywords :
Parkinsons disease, PD, dopamine agonists
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Amantadine hydrochloride is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Parkinson's disease.
- Apomorphine hydrochloride
- Bromocriptine
- Cabergoline
- Clonazepam
- Co-beneldopa
- Co-careldopa
- Entacapone
- Foslevodopa with foscarbidopa
- Levodopa with carbidopa and entacapone
- Melatonin
- Opicapone
- Orphenadrine hydrochloride
- Pergolide mesilate
- Pramipexole
- Procyclidine hydrochloride
- Rasagiline mesilate
- Ropinirole hydrochloride
- Rotigotine
- Safinamide
- Selegiline hydrochloride
- Tolcapone
- Trihexyphenidyl hydrochloride
Committee Recommendations (1)
Amantadine may be considered as an adjuvant where dyskinesia is not adequately managed by modifying existing therapy.
Initiation may be carried out in Primary Care but only after recommendation by a specialist.
Modifications to therapy should only be carried out on specialist advice.